Skip to content

Assessment of the Effect of an Implant System With a Novel Abutment Attachment Design on Crestal Bone Preservation

A Prospective Randomized-Controlled Evaluation of an Implant System With a Novel Abutment Attachment Design for the Preservation of Crestal Bone

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01529879
Acronym
Polaris
Enrollment
49
Registered
2012-02-09
Start date
2011-08-31
Completion date
2016-12-31
Last updated
2022-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Partial Edentulism, Tooth Disease

Keywords

edentulism, dental implants, clinical study, Nanotite Certain Tapered implant, randomized, crestal bone level

Brief summary

Integration success rates and the preservation of crestal bone will be higher for the experimental device than for the control implants.

Detailed description

In this study patients are randomized to receive either the experimental implant system or the control Nanotite Certain Tapered (standard abutment connection) and assessed for integration success measured by lack of implant mobility and lack of bone loss obtained at various study time points

Interventions

New abutment connection implant

Nanotite Certain Tapered (standard abutment connection) implant

Sponsors

ZimVie
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients of either sex and older than 18 years of age * patients needing at least one dental implant to treat partial edentulism * patients physically able to tolerate surgical and restorative dental procedures * patients agreeing to all protocol visits

Exclusion criteria

* patients with infection or severe inflammation at the intended treatment sites * patients smoking greater than 10 cigarettes per day * patients with uncontrolled diabetes mellitus * patients with uncontrolled metabolic diseases * patients who received radiation treatment to the head in the past 12 months * patients needing bone grafting at the intended treatment sites * patients known to be pregnant at screening visit * patients with para-functional habits like bruxing and clenching

Design outcomes

Primary

MeasureTime frameDescription
Cumulative success rate2 yearsCrestal bone regression (amount of bone loss measured) and equivalence in integration success (implant mobility)

Countries

Colombia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026